| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Oct 17, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 15.0 | -14,205 | -17.72% | ✓ | $1.3M |
| Oct 13, 2025 | Oct 15, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 35.0 | -10,070 | -3.65% | ✓ | $894.6K |
| Sep 10, 2025 | Sep 12, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 30.0 | -3,725 | -5.35% | ✓ | $293.6K |
| Aug 7, 2025 | Aug 8, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 26.3 | -5,500 | -8.28% | ✓ | $411.7K |
| Jul 9, 2025 | Jul 11, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 35.0 | -7,645 | -3.03% | ✓ | $614K |
| Jun 25, 2025 | Jun 27, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 26.3 | -10,800 | -7.88% | ✓ | $862.7K |
| Jun 6, 2025 | Jun 10, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 52.5 | -200 | -0.32% | ✓ | $16K |
| Jan 6, 2025 | Jan 8, 2025 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 95.0 | +16,267 | 37.21% | ✓ | $197.9K |
| Sep 16, 2024 | Sep 18, 2024 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 5.0 | -32,795 | -49.62% | ✓ | $3.2M |
| Aug 23, 2024 | Aug 27, 2024 | Nuvalent, Inc. | Chief Scientific Officer | Sell | 22.5 | -10,500 | -13.71% | ✓ | $893.3K |